CAH
Cardinal Health, Inc.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2013 | 52Q | $37 | $200 | +434% |
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $98 | $200 | +103% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
| Point72 Asset Management | Q3 2024(8Q snapshot) | 7Q | $104 | $200 | +92% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Glenview Capital 2× in & out | Q2 2023 | Q2 2024 | → $94 | +16% |
| Maverick Capital 3× in & out | Q3 2023 | Q4 2023 | → $99 | +11% |
| Scion Asset Management | Q3 2019 | Q4 2019 | → $46 | +30% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CARDINAL HEALTH INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 17, 2026 — the most recent Form 4 on file — not from today.
- Form 40000721371-26-000015Apr 17, 2026
- Form 40001945228-26-000002Mar 3, 2026
- Form 40001741576-26-000002Feb 18, 2026
- Form 40001517890-26-000002Feb 10, 2026
- Form 40002102673-26-000004Jan 20, 2026
- Form 40001771383-25-000005Dec 2, 2025
- Form 40001942639-25-000005Dec 2, 2025
- Form 40001945352-25-000005Dec 2, 2025
- Form 40001786065-25-000005Dec 2, 2025
- Form 40001754463-25-000006Dec 2, 2025
- Form 40001504970-25-000003Nov 6, 2025
- Form 40001390194-25-000006Nov 6, 2025
- Form 40000721371-25-000134Nov 6, 2025
- Form 40001584637-25-000003Nov 6, 2025
- Form 40001179497-25-000002Nov 6, 2025
Fundamentals
XBRL · Cardinal Health, Inc.Annual figures sourced directly from Cardinal Health, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CARDINAL HEALTH INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- 8-KMaterial eventMar 23, 2026
- 8-KMaterial eventMar 5, 2026
- 10-QQuarterly reportFeb 5, 2026
- 8-KMaterial eventFeb 5, 2026
- 8-KMaterial eventJan 13, 2026
- 8-KMaterial eventNov 6, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 30, 2025
- 8-KMaterial eventOct 10, 2025
- 8-KMaterial eventOct 3, 2025
- DEF 14AProxy statementSep 16, 2025
- 8-KMaterial eventAug 27, 2025
- 8-KMaterial eventAug 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | open | $104 | $200 | +92% |
| Two Sigma Investments | Q3 2024 | open | $104 | $200 | +92% |
| D.E. Shaw | Q3 2024 | open | $104 | $200 | +92% |
| AQR Capital Management | Q3 2024 | open | $104 | $200 | +92% |
| Millennium Management | Q3 2024 | open | $104 | $200 | +92% |
| Point72 Asset Management | Q3 2024 | open | $104 | $200 | +92% |
| Renaissance Technologies | Q3 2024 | open | $98 | $200 | +103% |
| Maverick Capital | Q3 2023 | Q4 2023 | $89 | $99 | +11% |
| Glenview Capital | Q2 2023 | Q2 2024 | $81 | $94 | +16% |
| Maverick Capital | Q3 2021 | Q1 2022 | $47 | $48 | +2% |
| Maverick Capital | Q2 2020 | Q2 2021 | $42 | $50 | +20% |
| Bridgewater Associates | Q2 2020 | open | $41 | $195 | +380% |
| Scion Asset Management | Q3 2019 | Q4 2019 | $35 | $46 | +30% |
| Glenview Capital | Q1 2018 | Q3 2018 | $53 | $40 | -24% |
| Bridgewater Associates | Q1 2018 | Q1 2020 | $52 | $51 | -2% |
| Bridgewater Associates | Q2 2015 | Q3 2017 | $65 | $52 | -20% |
| Bridgewater Associates | Q3 2013 | Q4 2014 | $37 | $59 | +58% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.